
0:00
44:35
Tom Weaver, scientist, serial entrepreneur, and co-founder and chairman of CellCodex, discusses his career building biotechnology companies, the importance of translating scientific innovation into successful products, and the potential of AI-driven drug discovery to transform our ability to treat disease.
Our host, Grant Belgard, is also a co-founder and the CTO of CellCodex.
The Bioinformatics CRO serves the computational biology needs of academic researchers, nonprofits, and biotechnology and pharmaceutical companies.
More episodes from "The Bioinformatics CRO Podcast"



Don't miss an episode of “The Bioinformatics CRO Podcast” and subscribe to it in the GetPodcast app.








